References
- Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325(5): 303–10
- The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325(5): 293–302
- Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989; 261(6): 884–8
- Stevenson LW. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant 1991; 10(3): 468–76
- Stevenson LW, Brunken RC, Belil D, et al. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol 1990;15 (1): 174–80
- Stevenson LW, Ullisch JH. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation 1986: 74(6): 1303–8
- Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with Captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol 1992; 19(4): 842–50
- Cody RJ. Management of refractory congestive heart failure. Am J Cardiol 1992: 69(18): 141–7G, disc 147–9G
- Reedy JE, Pennington DG, Miller LW, et al. Status I heart transplant patients: conventional versus ventricular assist device support. J Heart Lung Transplant 1992; 11(2Pt 1): 246–52
- Stevenson LW, Miller LW. Cardiac transplantation as therapy for heart failure. Curr Probl Cardiol 1991;16(4): 217–305
- Kaye MP. The registry of the International Society for Heart and Lung Transplantation: ninth official report—1992. J Heart Lung Transplant 1992;11(4): 599–606
- Stevenson LW, Sietsema K, Tillisch JH, et al. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation 1990;81(1): 78–85
- Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83(3):778–86
- Stevenson LW, Tillisch JH, Hamilton M, et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990; 66(19): 1348–54
- Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73(2): 257–67
- Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation 1991; 84(1): 40–8
- Conti JB, Milk RM Jr. Mitral regurgitation and death while awaiting cardiac transplantation. Am J Cardiol 1993:71(7): 617–8
- O'Connell JB, Bourge RC, Costanzo-Nordin MR, et al. Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992:86(3): 1061–79
- Erickson KW, Costanzo-Nordin MR, O'Sullivan EJ, et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant 1990;9(5): 526–37
- Schocken DD, Arrieta MI, Leaverton PE, et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20(2): 301–6
- Bevensen E, ed. UNOS Update 1992; 8(10):4–47
- Stevenson LW, Hamilton MA, Tillisch IH, et al. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens. J Am Coll Cardiol 1991; 18(4):919–25